Home/Filings/4/0001567619-23-002403
4//SEC Filing

Stanker James H 4

Accession 0001567619-23-002403

CIK 0001533743other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 5:20 PM ET

Size

4.6 KB

Accession

0001567619-23-002403

Insider Transaction Report

Form 4
Period: 2023-02-09
Stanker James H
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-02-09$0.80/sh+12,500$10,00061,750 total

Documents

1 file

Issuer

Processa Pharmaceuticals, Inc.

CIK 0001533743

Entity typeother

Related Parties

1
  • filerCIK 0001681718

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:20 PM ET
Size
4.6 KB